FINWIRES · TerminalLIVE
FINWIRES

Onto Innovation's Rigaku Deal Boosts Position in Semiconductor Process Control, Oppenheimer Says

By

Onto Innovation's (ONTO) acquisition of a 27% stake in X-ray hardware firm Rigaku strengthens its competitive edge in next-generation semiconductor process control, Oppenheimer said in a note Monday.

The company is anticipating that X-ray metrology will become much more important, and combining its software with Rigaku's hardware will enable it to capture a core position in the metrology category before it fully matures, analysts said.

Onto's investment in Rigaku, valued at about $710 million, is expected to be financially accretive by late 2026, and give Onto a board seat on Rigaku for strategic alignment, according to the note.

Advanced V-NAND and DRAM customers have already adopted the integrated systems, while there is growing interest from other logic and memory manufacturers, analysts said.

Oppenheimer reiterated its outperform rating on the stock, with a $350 price target.

Price: $291.76, Change: $-3.33, Percent Change: -1.13%

Related Articles

Wire

IDP Education to Introduce Malaysia as Study Destination

IDP Education (ASX:IEL) expanded its range of study destinations by supporting students to study in Malaysia, according to a Tuesday statement.The company cited changing student preferences as a reason for the move, with growing demand for new destinations offering strong education quality, career outcomes, and affordable study options.The initial rollout will focus on a select number of markets as part of a phased pilot.IDP Education's shares declined 1% in recent trading on Tuesday.

ASX:IEL
Wire

Infratil Says Moody's Assigns CDC Data Centers 'Baa2' Rating, Stable Outlook

Infratil (NZE:IFT, ASX:IFT) said Moody's Ratings has assigned CDC Data Centers Australia its first public investment grade credit rating of "Baa2" with a stable outlook, according to Tuesday filings with the Australian and New Zealand bourses.The rating reflects CDC's strong financial position, stable long-term contracted revenues, and exceptionally long lease durations averaging 28.4 years, per the filing.The rating will enable CDC to improve access to capital markets, supporting further large-scale infrastructure development driven by rising demand from government, hyperscale cloud providers, and critical industries, the filing added.The company's Kiwi shares shed 1% in recent Tuesday trade.

ASX:IFTNZE:IFT
Wire

Spruce Biosciences Begins Public Offering of Stock, Prefunded Warrants; Shares Fall After Hours

Spruce Biosciences (SPRB) said late Monday it commenced an underwritten public offering of common shares or related prefunded warrants.The company expects to grant underwriters a 30-day option to buy up to 15% more stock at the public offering price, less underwriting discounts and commissions.The offering is subject to market and other conditions, Spruce said.Spruce shares fell 13% in after-hours trading.

$SPRB